
    
      The intent is to monitor exhaled aerosol produced by COVID-19 patients pre and post aerosol
      generating procedures. Monitoring will occur at a distance of 1 and 3 feet from the subject's
      airway. This observational study will be conducted in standard patient hospital rooms
      (standard or negative pressure room).
    
  